Cambridge Cognition Holdings PLC
COG
Company Profile
Business description
Cambridge Cognition Holdings PLC is a neuroscience digital health company specializing in the precise measurement of clinical outcomes in neurological disorders. Geographically, it derives majority of its revenue from the United States of America and also has a presence in the United Kingdom, European Union, and Rest of world. The company services include Neuroscience consultancy, Technical consultancy, Study design, Data analysis, Study management, Data management, and Reports and interpretation.
Contact
Tunbridge Court, Tunbridge Lane
Bottisham
CambridgeCB25 9TU
GBRT: +44 1223810700
Sector
Healthcare
Stock type
Defensive
Industry
Health Information Services
Fiscal Year End
31 December 2026
Employees
84
Stocks News & Analysis
stocks
Eli Lilly receives FDA approval to add another oral GLP-1 to market
Wide moat Eli Lilly receives FDA approval for obesity pill.
stocks
Our top ASX picks in every sector
These companies are our favourite choices for investors wanting to boost Aussie equity exposure.
stocks
Which of the 3 giant AI IPOs should you buy?
OpenAI, Anthropic, and Databricks are expected to go public this year at massive valuations.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,774.90 | 124.80 | -1.40% |
| CAC 40 | 7,908.82 | 72.45 | -0.91% |
| DAX 40 | 22,916.77 | 382.12 | -1.64% |
| Dow JONES (US) | 46,196.17 | 369.57 | -0.79% |
| FTSE 100 | 10,393.58 | 28.79 | 0.28% |
| HKSE | 25,116.53 | 177.50 | -0.70% |
| NASDAQ | 21,612.97 | 227.98 | -1.04% |
| Nikkei 225 | 52,463.27 | 1,276.41 | -2.38% |
| NZX 50 Index | 12,902.15 | 76.28 | 0.59% |
| S&P 500 | 6,527.28 | 48.04 | -0.73% |
| S&P/ASX 200 | 8,579.50 | 105.50 | -1.21% |
| SSE Composite Index | 3,919.29 | 29.27 | -0.74% |